Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01980992 · ClinicalTrials.gov registry record · Phase 1
Oral Immunotherapy for Wheat Allergy
A Phase 1 study, sponsored by Hugh A Sampson, MD.
- Completed
- Registry status
- Phase 1
- Development phase
- 46
- Enrollment target
NCT01980992 is a Phase 1 study that has completed, run by Hugh A Sampson, MD. The registered enrollment target is 46 participants.
The verdict
NCT01980992, a Phase 1 study, has completed, sponsored by Hugh A Sampson, MD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 46 participants
- Enrollment target
Study Summary
This study is being done to learn about the medical effects, the safety, and the immunologic effects of Wheat Oral Immunotherapy (OIT) treatment. The goal of the study is to find out whether subjects can develop the ability to eat wheat (the food allergen) regularly without allergic symptoms after stopping the study treatment.
Interventions
- DRUG Wheat OIT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2013-10 |
| Est. Completion | 2017-04-13 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01980992
The ClinicalTrials.gov registry entry for NCT01980992 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hugh A Sampson, MD, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Wheat OIT is the first listed.
NCT01980992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01980992 about?
NCT01980992 is a clinical study titled "Oral Immunotherapy for Wheat Allergy". This study is being done to learn about the medical effects, the safety, and the immunologic effects of Wheat Oral Immunotherapy (OIT) treatment. The goal of the study is to find out whether subjects can develop the ability to eat wheat (the food allergen) regularly without allergic symptoms after s...
What is the current status of trial NCT01980992?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 46 participants. The study started on 2013-10. Estimated completion is 2017-04-13.
What interventions are being tested in trial NCT01980992?
The interventions under investigation include: Wheat OIT (DRUG).
Who is sponsoring clinical trial NCT01980992?
This trial is sponsored by Hugh A Sampson, MD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.